This quarter’s healthcare newsletter highlights the launch of ChatGPT Health, how celebrity influence on colon cancer spiked awareness and action with screenings, and the launch of TrumpRx created to find the lowest prices on prescription drugs.
OpenAI has launched ChatGPT Health, a new feature that allows users to upload and integrate their medical data to receive personalized healthcare information.
OpenAI Launches ChatGPT Health to Analyze User Medical Data
ChatGPT Health has introduced a new way for consumers to centralize their medical data, giving them personalized healthcare recommendations tied directly to their own health information. This launch reflects a consumer shift toward AI-powered tools that simplify complex health data and provide clarity where previous technologies fell short.
This feature allows users to securely connect their medical records and health apps such as Apple Health, MyFitnessPal, and lab testing services so the AI can provide more personalized, context-aware responses to health and wellness questions. The feature is designed to help users better understand test results, prepare for doctor visits, and manage everyday health decisions, while explicitly not replacing clinical care.
At the same time, the move raises important questions about trust and data protection. As consumers become more willing to exchange sensitive information for AI-driven insights, OpenAI’s ability to maintain strong privacy protections and transparent practices will become increasingly more important.
OpenAI officially launched ChatGPT Health in January 2026, initially rolling it out to a limited group of users, with plans to expand availability more broadly. Google Gemini and other AI platforms are likely to develop competing features. The success of all models will be dependent on the public’s willingness to integrate medical data which will ultimately shape how widely and confidently AI Health tools are adopted.
ChatGPT Health is a new way for consumers to get answers to their health-related questions instantly and, based on the waitlist to use this tool, will be widely used across generations. As new AI Health tools emerge, healthcare organizations should be focused on this new environment and expect patients to feel more empowered and informed on their healthcare decisions.
Source: https://www.emarketer.com/content/openai-launches-chatgpt-health-analyze-user-medical-data
James Van Der Beek’s death triggered a dramatic 140% spike in colon cancer screening appointments on Zocdoc. This rise reveals how sudden, high profile health events can reshape consumer behavior in real time.
Celebrity Tragedy Drives Health Action
If there could be any silver lining to the tragic passing of James Van Der Beek to colon cancer, it’s the public awareness he brought to the topic which likely could save and change the course of many people’s lives. Open about his diagnosis and medical journey, James Van Der Beek’s passing inspired a dramatic 140% increase in colon cancer screenings on the day of his death proving the influence and attention he had on this topic.
Colorectal cancer is on the rise amongst younger people. 1 in 5 new cases now occur in those under the age of 55, doubling from 1 in 10 in 1995; yet based on a March 2025 MedStar Health Survey, 79% of people are unaware of the recommended age to begin colonoscopy screenings. Based on this stat, it’s clear that there is room for greater education on critical preventative measures.
Healthcare systems should use this moment to close gaps in screening education, make age guidelines more visible, simplify access to appointments, and be prepared to respond quickly when public attention increases. Cultural events can prompt immediate action in ways traditional outreach often cannot, and potentially leveraging trusted celebrities or influencers in advertising or awareness campaigns can help amplify these messages. Organizations that meet this momentum with clear information, easy scheduling, and targeted outreach to younger adults can turn a brief surge in concern into sustained preventive behavior.
President Trump introduces TrumpRx as part of his effort to lower drug costs. This new government website was created to help patients look up prescription medications and then purchase them elsewhere using their own money.
TrumpRx Broadens Drug Cost Comparison
TrumpRx attempts to serve as a central resource for consumers to view cash prices and then purchase medications directly through pharmacies or manufacturer websites. This launch confirms the agreements his administration reached with major drugmakers to lower certain prices and shift some production back to the U.S. The site lists a broad range of drugs, including insulin, inhalers, weight loss medications, and fertility treatments, with prices that vary significantly across products.
For most insured Americans, TrumpRx is currently unlikely to provide meaningful savings. Many of the listed medications already have low co-pays or affordable generic alternatives, making cash payment options potentially more expensive. The platform itself advises consumers with insurance to check their co-pay before choosing a cash price.
However, TrumpRx will be most helpful for people who pay out of pocket for medications their insurance doesn’t cover, especially those seeking weight loss or fertility drugs. For families navigating IVF costs, the discounted fertility medications could offer real financial relief. It also provides a temporary option for uninsured patients or anyone stuck waiting on insurance approvals. Overall, the biggest impact will be on niche groups facing high out-of-pocket costs, not the broader insured population.
TrumpRx is expected to grow with more prescription drugs coming soon. With more options for the consumer, healthcare systems have the opportunity to lead as a trusted authority who helps patients sort through pricing tools, compare options, and understand when insurance or generics may offer better value.
Source: https://www.nytimes.com/2026/02/05/health/trumprx-online-drugstore-prices.html
For more information, visit harmelin.com, or connect with us on LinkedIn or Facebook.
